These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9881113

  • 1. Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance.
    Tanabe H, Tasaka S, Ohmori H, Gomi N, Sasaki Y, Machida T, Iino M, Kiue A, Naito S, Kuwano M.
    Bioorg Med Chem; 1998 Nov; 6(11):2219-27. PubMed ID: 9881113
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance.
    Tasaka S, Ohmori H, Gomi N, Iino M, Machida T, Kiue A, Naito S, Kuwano M.
    Bioorg Med Chem Lett; 2001 Jan 22; 11(2):275-7. PubMed ID: 11206476
    [Abstract] [Full Text] [Related]

  • 3. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance, calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents.
    Kiue A, Sano T, Suzuki K, Inada H, Okumura M, Kikuchi J, Sato S, Kohno K, Kuwano M.
    Cancer Res; 1990 Jan 15; 50(2):310-7. PubMed ID: 1967223
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T, Koike K, Ohga T, Kubo T, Wada M, Kohno K, Mori T, Hidaka K, Kuwano M.
    Br J Cancer; 1995 Aug 15; 72(2):418-23. PubMed ID: 7640227
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
    Watanabe Y, Takano H, Kiue A, Kohno K, Kuwano M.
    Anticancer Drug Des; 1991 Feb 15; 6(1):47-57. PubMed ID: 2015041
    [Abstract] [Full Text] [Related]

  • 10. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
    Sadzuka Y, Egawa Y, Sawanishi H, Miyamoto K, Sonobe T.
    Toxicol Lett; 2002 Sep 05; 135(1-2):137-44. PubMed ID: 12243872
    [Abstract] [Full Text] [Related]

  • 11. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J, Ferry DR, Boer R, Gekeler V, Ise W, Kerr DJ.
    Eur J Pharmacol; 1994 Dec 15; 288(1):105-14. PubMed ID: 7705462
    [Abstract] [Full Text] [Related]

  • 12. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC, Hayashi M, Fukami A, Obata R, Sunazuka T, Tomoda H, Komiyama K, Omura S.
    J Antibiot (Tokyo); 2000 Oct 15; 53(10):1201-6. PubMed ID: 11132967
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E, Matsushita R, Negishi H, Nomura M, Harada S, Yamamoto H, Miyamoto K, Ichimura F.
    J Pharm Sci; 1995 Oct 15; 84(10):1205-9. PubMed ID: 8801335
    [Abstract] [Full Text] [Related]

  • 15. In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.
    Kraus-Berthier L, Guilbaud N, Peglion JL, Leonce S, Lombet A, Pierre A, Atassi G.
    Acta Oncol; 1994 Oct 15; 33(6):631-7. PubMed ID: 7946440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
    Chen ZS, Aoki S, Komatsu M, Ueda K, Sumizawa T, Furukawa T, Okumura H, Ren XQ, Belinsky MG, Lee K, Kruh GD, Kobayashi M, Akiyama S.
    Int J Cancer; 2001 Jul 01; 93(1):107-13. PubMed ID: 11391629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
    Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T.
    Cancer Res; 1991 May 01; 51(9):2420-4. PubMed ID: 1673087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.